Parenteral Drug (India) share news and announcements
BSE: 524689Pharmaceuticals & Biotechnology
Trading suspended since 3 Feb 2025
Last traded ₹2.90 on 21 Aug 2023
Parenteral Drug (India) share news and announcements
782 announcements, routine notices left out, newest first. Page 14 of 16.
Mar 2014
18 Mar · Management
Proposed resignation of Mr. Yogesh Khakre from the post of Company Secretary and Compliance Officer of the Company w.e.f. March 01, ....4 Mar · Legal
Price movement : Significant price movement has been observed in Parenteral Drugs (India) Limited.. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Parenteral Drugs (India) Limited has vide its letter inter-alia stated,"The present situation in the prices of the shares of the Company is due to the market forces and not because of the reason known to the management of the Company, as the Promoters of the Company are not trading in the shares of the Company."4 Mar · Legal
With reference to increase in the share prices of the Company across the Exchanges in the recent past, Parenteral Drugs India Ltd has clarified to BSE that the present situation in the ....
Feb 2014
14 Feb · Limited Review for Dec 31, 2013
Nov 2013
11 Nov · Updates
Company received from M/s. Mahaganpati Investment Private Limited, Rs. 9,98,32,668/- towards the outstanding call money (including premium) on 18,26,898 partly paid-up 0% redeemable preference shares out of which Rs. 8.90 is paid towards face value and Rs. 45.746 towards premium; the shares will now be treated as fully-paid up.11 Nov · Acknowledge Receipt of Call Money due on Partly Paid Up 0% Redeemable Preference Shares
Company do receive from M/s. Mahaganpati Investment Private Limited, Rs. 9,98,32,668/- towards the outstanding call money (including ....
Oct 2013
30 Oct · Board meeting
Board of Directors of the Company at its meeting held on October 30, 2013, inter alia, has issued and allotted 39,49,469 Fully Paid-up ....18 Oct · Board Meeting on Oct 30, 2013
Meeting of the Board of Directors of the Company will be held on October 30, 2013, inter alia, to consider the Allotment of 39,49,469 ....
Sep 2013
16 Sep · Management
Shri Satish Moreshwar Joshi, the Nominee of State Bank of India be and is hereby appointed as a Nominee Director of the Company w.e.f. 16.08.2013 in terms of letter of approval by CDR-EG.
Aug 2013
30 Aug · Corporate action
Register of Members and Share Transfer Books of the Company shall remain closed from September 27, 2013 to September 30, 2013(both days inclusive) for the purpose of Annual General Meeting.29 Aug · Corporate action
Register of Members & Share Transfer Books of the Company will remain closed from September 27, 2013 to September 30, 2013 (both days ....14 Aug · Limited Review for June 30, 2013
6 Aug · Board meeting
To consider inter-alia un-audited financial results of the Company for the first quarter ended on June 30, 2013.
Jul 2013
May 2013
14 May · Board meeting
Company had informed the Exchange regarding the meeting of the Board of Directors of the Company scheduled to be held on May15, 2013 To consider inter-alia un-audited financial results of the Company for the Fourth quarter ended On March 31, 2013.The Company has now informed the Exchange that aforesaid meetings will now rescheduled to be held on May 30, 2013.Not held on this date
6 May · Management
Company has appointed Mr. Yogesh Khakre as the Company Secretary & Compliance Officer of the Company w.e.f. April 01, 2013 and Ms. Archna Agar has submitted her resignation from the post of Company Secretary and Compliance Officer w.e.f. March 31, 2013. Consequently, she has ceased to be the designated Compliance Officer of the Company w.e.f. that date.3 May · Board meeting
To consider inter-alia un-audited financial results of the Company for the Fourth quarter ended On March 31, 2013.3 May · Change in Company Secretary & Compliance Officer
Company has appointed Mr. Yogesh Khakre as the Company Secretary & Compliance Officer of the Company w.e.f. April 01, 2013. and Ms. ....
Apr 2013
Mar 2013
15 Mar · Updates
One of the wholly owned subsidiaries of the Company M/s. Goa Formulations Limited has executed an agreement with M/s.Fresenius Kabi India Private Limited to sell its only pharmaceutical manufacturing unit at Goa at a consideration of Rs.200 Cr. and the agreement has become binding on the parties. Further, Parenteral Drugs (India) Limited has also accorded its consent to the transaction as the holding company.15 Mar · Sale of Unit by a Subsidiary Company
That one of the wholly owned subsidiaries of the Company M/s. Goa Formulations Limited has executed an agreement with M/s. Fresenius Kabi ....
Jan 2013
30 Jan · Limited Review for Dec 31, 2012